Opiant Pharmaceuticals Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Corporate Update

SANTA MONICA, Calif., March 04, 2020 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc.?(?Opiant?) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions and drug overdose, today reported financial results for the fourth quarter and year ended?December 31, 2019,?and provided a corporate update.?